ArticleWorld journal of hepatology2022

Efficacy and safety of sofosbuvir/velpatasvir with or without ribavirin in hepatitis C genotype 3 compensated cirrhosis: A meta-analysis.

Jing Hong Loo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.